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study. POTS prevalence in adult patients with CFS was 5.7% vs. 6.9% in non-CFS adults (P = 0.54). In adolescents, prevalence rates were 18.2% and 17.4%, respectively (P = 0.93). Adult patients with POTS-CFS were younger (30 AE 12 vs. 40 AE 13 years, P = 0.001) and had a higher supine heart rate (71 AE 11 vs. 65 AE 9 beats per min, P = 0.009) compared with non-POTS-CFS patients. Severity and activity patterns did not differ between groups. In patients with CFS, criteria for Systemic Exertion Intolerance Disease (SEID) were met in 76% of adults and 67% of adolescents. In these patients with CFS fulfilling the SEID criteria, the prevalence of POTS was not different from that in the overall CFS population. POTS-CFS adolescents had less clinically significant improvement after CBT than non-POTS-CFS adolescents (58% vs. 88%, P = 0.017).
Introduction
Chronic fatigue syndrome (CFS) is a debilitating disease with a prevalence ranging between 200 and 1400 per 100 000 persons in both Europe and the USA [1] [2] [3] [4] . With fatigue as the most characteristic symptom, patients with CFS often report a variety of other symptoms, such as unrefreshing sleep, postexertional malaise and headaches [5] . More than 25% of patients report having had symptoms more than 5 years before being diagnosed with CFS [1] , which illustrates the difficulties encountered in the diagnostic process. Trying to overcome this problem, several research groups have proposed new CFS criteria [5] [6] [7] since the first case definition published by the Centre for Disease Control and Prevention (CDC) in 1988 [8] . However, despite the use of different case formulations, none of these diagnostic methods has been sufficiently tested [9] , and substantial heterogeneity remains in addition to difficulties in distinguishing fatigue caused by CFS from other fatigue-causing illnesses and idiopathic fatigue.
In an attempt to improve the diagnostic process, the Institute of Medicine (IOM) recently proposed a new case definition [1] , with a new name to describe the illness more accurately: systemic exertion intolerance disease (SEID). The aim of this new definition is a better understanding of CFS, with objective measurements to diagnose patients. In order to fulfil the SEID criteria, a patient must have three core symptoms: (i) severe fatigue that is present for at least 6 months leading to substantial impairment, (ii) postexertional malaise and (iii) unrefreshing sleep. Additionally, a patient must be diagnosed with cognitive impairment, orthostatic intolerance (OI) or both. The advantage of including OI is that most forms can be diagnosed in an objective manner, by measuring heart rate and blood pressure during an active standing or headup tilt test.
Orthostatic intolerance is defined as a syndrome in which patients report symptoms in upright position, with (delayed) orthostatic hypotension, reflex syncope and postural orthostatic tachycardia syndrome (POTS) as the most common clinical manifestations [10] [11] [12] [13] ; the latter is reported most frequently in the CFS population, and several studies have been conducted to evaluate the prevalence of POTS in CFS [14] [15] [16] . Based on the literature search conducted by the IOM, the prevalence of POTS is 27% in patients with CFS compared to 4% in healthy control subjects. The studies included in the review report a wide variety in duration and type of orthostatic testing. The recommended duration of testing is at least 10 min [10, 13] , although several of the reviewed studies took into account only the first few minutes [14, 16] .
Postural orthostatic tachycardia syndrome is defined as an increase in heart rate of at least 30 beats per min (bpm) or an increase to 120 bpm within the first 10 min after attaining an upright position in the absence of orthostatic hypotension [12, 13] . POTS is predominantly reported in women [17] , and hypovolaemia, deconditioning and increased sympathetic activity have been described as possible pathophysiological mechanisms [17, 18] . Some studies have shown that CFS patients with POTS (patients with POTS-CFS) have shorter symptom duration, are younger [14] and report less severe fatigue than CFS patients without POTS (non-POTS-CFS patients) [15] , although others did not find differences with respect to symptom severity [19] . If POTS in CFS could be explained by deconditioning, patients with POTS-CFS would be expected to be less physically active. However, to our knowledge, this has never been investigated. Furthermore, it is unknown whether patients with POTS-CFS respond differently, compared with non-POTS-CFS patients, to cognitive behavioural therapy (CBT), which is an evidence-based treatment for CFS [20, 21] . Before incorporating OI and POTS into a new case definition, the impact of POTS on CFS-related symptoms and treatment outcome should be known.
To overcome these problems, a large CFS population was studied prospectively to evaluate whether the prevalence of POTS is in accordance with the IOM report. As recommended, testing duration was longer than 10 min in all patients [13] . POTS prevalence was also determined in patients with persistent fatigue who did not meet the CDC consensus for CFS (non-CFS patients), to evaluate the extent to which the presence of POTS discriminates between CFS and non-CFS fatigued patients. The prevalence of POTS in patients with CFS fulfilling the SEID criteria was also evaluated. Furthermore, we examined whether patients with POTS-CFS report more symptoms associated with POTS (e.g. dizziness), are more fatigued or impaired, have a lower level of physical activity or respond differently to CBT compared with non-POTS-CFS patients.
Materials and methods

Study design and participants
Between June 2013 and December 2014, all patients consecutively referred to the Expert Centre for Chronic Fatigue (ECCF) at the Radboud University Medical Centre underwent a standardized blood pressure measurement as part of their clinical assessment. Furthermore, patients filled out web-based questionnaires, and during a period of 2 weeks kept a diary recording symptoms and wore a motion-sensing device (actometer). In this study, we defined patients with CFS as those diagnosed with CFS according to the CDC criteria [5] . In this patient category, the proportion of patients fulfilling the SEID criteria, omitting the criterion of OI, was also evaluated. Non-CFS fatigued patients were included if they reported persistent fatigue not meeting the CDC consensus criteria for CFS. Patients were excluded if blood pressure measurement was not conducted in accordance with the protocol, or if they had not filled in the questionnaires.
The local institutional ethics review board approved this study. Informed consent was not required because all measurements were performed as part of routine care.
Blood pressure measurement
Blood pressure measurement and POTS identification were performed using an active standing test. First, heart rate and blood pressure were recorded at 2-to 3-min intervals whilst the patient was in the supine position for 15 min using an electronic automated device (Mobil-O-Graph, I.E.M., Stolberg, Germany). Next, patients were instructed to stand upright without assistance and remain in this position for the next 14-18 min. After standing for 5-8 min, blood pressure measurement was resumed for the remaining period.
POTS was defined as an increase in heart rate of at least 30 bpm compared to the supine position, or a standing heart rate of ≥120 bpm for any of the measurements within the first 10 min after attaining an upright position [13] . Supine blood pressure and heart rate were calculated using the mean of the last five measurements before standing. The first three standing measurements were used to determine the mean blood pressure and heart rate in the upright position. Only patients without signs of orthostatic hypotension within the first 10 min, defined as a decrease in systolic blood pressure of ≥20 mmHg or diastolic blood pressure of ≥10 mmHg, could be identified as having POTS.
Actometer and diary score Activity was measured using an actometer, a motion-sensing device that measures physical activity, which is worn at the ankle during 12 consecutive days and nights as part of the standard diagnostic work-up at our centre. The small, light (26 g) device contains a sensor that is sensitive in three directions [22, 23] . When an acceleration passes the predefined threshold, the motion is registered as activity. The acquired information can be used to calculate a mean activity score during the time awake; this score is expressed as the average number of accelerations per 5-min period. The mean activity score over 12 days for patients with CFS has been reported to be 66 AE 22 [23] . When patients scored above 66 on not more than 1 day of the 12 days, they are labelled as low active; a score of >66 on 2-9 days and on 10-12 days is considered relatively active and highly active, respectively.
During the same 12-day period, patients kept a diary recording symptoms four times daily. Patients recorded the presence of concentration problems, decreased memory, visual problems, dizziness, shortness of breath, headache, constipation/diarrhoea, feeling tense, irritability and nausea. For each time-point, patients reported symptoms to be present or absent. A mean symptom prevalence score per time-point over 12 days was calculated using the formula: number of days the symptom was present divided by the number of days the diary was kept, multiplied by 100 [24] . The mean of the four different timepoints was used to calculate the total symptom score.
Questionnaires
Fatigue severity was measured using the subscale fatigue severity of the Checklist Individual Strength (CIS-f). Scores range between 8 and 56 (eight items, seven-point Likert scale). The CIS is often used to measure fatigue in patients with CFS and has excellent psychometric characteristics [25] . A score of ≥35 reflects the presence of severe fatigue [26] . CIS-f scores were also collected for patients after completing CBT. The presence of additional CFS symptoms as defined by the CDC case definition during the previous 6 months was also assessed with a questionnaire. The level of functional impairment was measured using the Sickness Impact Profile (SIP8) total score. The SIP evaluates disease-related physical and mental disabilities [27] . The presence of depressive symptoms was measured using the Becks Depression Inventory (BDI) primary care version, the score of which can range between 0 and 28 [28] .
Other variables collected using questionnaires were age, gender, body mass index, duration of symptoms, use of medication (opioids, sleep medication, and antidepressant, anxiolytic, anticonvulsive, antipsychotic, antihypertensive and stimulant drugs) and the presence of comorbid diseases.
Statistical analysis
Blood pressure data, acquired with Hypertension Management software 3.0 (I.E.M.), were exported to an Access database (Microsoft, Redmond, WA, USA) and combined with other relevant variables. All statistical analyses were conducted using IBM SPSS statistics version 22 (IBM, Armonk, NY, USA). All continuous variables are presented as means and standard deviations (SD) or medians and ranges, and categorical variables as percentages. For all reported variables, patients with POTS-CFS were compared to non-POTS-CFS patients. Furthermore, patients with CFS were compared to non-CFS patients with respect to fatigue severity, disabilities and blood pressure-related characteristics. A final comparison was made between patients with CFS and those patients with CFS who fulfilled the SEID criteria with respect to POTS prevalence. All categorical variables were compared using Pearson's chi-squared or Fisher's exact tests, depending on the observed frequency within each category. Continuous variables were compared using an independent Student's t-test. Statistical significance was set at 5% (P < 0.05). To correct for multiple testing, a Bonferroni correction was used when comparing use of medication, the presence of comorbid disorders and diary scores between groups.
Results
During the study period, 863 fatigued patients underwent blood pressure measurement at the ECCF and filled in questionnaires. Overall, 103 patients were excluded because the blood pressure measurement was not appropriate to determine the presence of POTS: no measurements in the standing position (n = 34), first standing measurement after 10 min (n = 35), standing measurement ≤10 min (n = 33) or no repeated measurement in the supine position (n = 1). Of the 760 remaining patients, 419 were diagnosed with CFS (331 adults, 88 adolescents) and 341 could not be diagnosed with CFS (318 adults, 23 adolescents) due to fatigue as a consequence of a psychiatric illness (n = 76) or a chronic somatic illness (n = 41), fatigue after cancer treatment (n = 57) or fatigue not fulfilling the CDC consensus with respect to severity or accompanying symptoms (n = 167). In those patients who fulfilled the CFS criteria, the SEID criteria were met in 75.8% of adults (251/331) and 67.0% of adolescents (59/ 88).
POTS prevalence in CFS, SEID and non-CFS patients
The prevalence of POTS was 8.4% (35/419) within the total CFS population, and 5.7% for adults (19/ 331) and 18.2% for adolescents (16/88). The POTS prevalence was not different between patients with (BDI ≥4) and without a clinically significant level of depressive symptoms (5.8% vs. 5.7%, P = 0.96). In patients with CFS fulfilling the SEID criteria, POTS was present in 5.2% of adults (13/251) and 22.0% of adolescents (13/59), which was not significantly different from the POTS prevalence in the overall CFS population (P = 0.77 and P = 0.57, respectively). In the non-CFS fatigued population, POTS was present in 6.9% (22/318) of adults and 17.4% (4/23) of adolescents, which was not statistically different from patients with CFS (P = 0.54 and P = 0.93, respectively).
Comparison of CFS and non-CFS patients: fatigue, disability and blood pressure
With respect to age, there were no differences between adult CFS and non-CFS patients (40 vs. 40 years, P = 0.82), as shown in Table 1 . Similarly there were no significant differences between adolescent CFS and non-CFS patients (mean age 16 and 17 years, respectively, P = 0.056). Although non-CFS patients were severely fatigued with a mean CIS-f of 48, they were less fatigued than patients with CFS (mean CIS-f 50, P < 0.001). This was also true for adolescent non-CFS and CFS patients (mean CIS-f 44 vs. 50, P = 0.001). Furthermore, patients with CFS were more impaired than non-CFS patients (mean SIP total score 1548 vs. 1198, P < 0.001). Mean blood pressure and heart rate in the supine and upright positions did not differ between groups.
Comparison of POTS-CFS and non-POTS-CFS patients: demographics and blood pressure Table 2 summarizes the comparison of demographic and blood pressure-related characteristics between POTS-CFS and non-POTS-CFS patients. Amongst adults, female patients were equally distributed between the two groups, and patients with POTS-CFS were significantly younger (30 vs. 40 years, P = 0.001). Furthermore, heart rate in the supine position was higher in patients with POTS-CFS (71 vs. 65 bpm, P = 0.009), which as expected was also found whilst standing (102 vs. 79 bpm, P < 0.001). Other variables did not differ between groups, although patients with POTS-CFS tended to have a lower blood pressure in the supine position than non-POTS-CFS patients. When comparing adolescents, the only variable that differed between groups was heart rate in the standing position, which was higher in patients with POTS-CFS (99 vs. 86 bpm, P < 0.001).
Comparison of POTS-CFS and non-POTS-CFS patients: symptoms, disability, activity patterns, comorbidity and use of medication
There were no significant differences between POTS-CFS and non-POTS-CFS patients with respect to fatigue severity, number of CDC symptoms, reported disabilities and depressive symptoms (Table 3) . Mean activity scores also did not differ between groups. The prevalence of all 10 different symptoms assessed with the diary score was not significantly different between groups (data not shown).
A total of 10.5% (n = 2) of POTS-CFS adults used antidepressants, compared with 18.6% (n = 58) of non-POTS-CFS patients (P = 0.54); antihypertensive drugs were, respectively, used by 5.3% (n = 1) and 11.2% (n = 35, P = 0.71). These drugs were rarely used by adolescents (antidepressants, n = 1 CFS patient; antihypertensive drugs, n = 1 CFS patient). The presence of other medical conditions in addition to CFS was distributed equally between all groups (data not shown).
Therapy outcome
In December 2015, 62% of adults and 63% of adolescents had completed CBT; patients who did not finish CBT were still following therapy sessions, were referred for treatment outside the ECCF or decided not to start therapy after the diagnostic process. Figure 1a shows the mean decrease in CIS-f scores after treatment compared to scores before treatment for patients who completed CBT. Figure 1b shows the percentage of patients with a CIS-f score of ≤35, which can be considered as no longer being severely fatigued [29] . Amongst adults, POTS-CFS and non-POTS-CFS patients responded similarly to CBT. However, fewer adolescents with POTS-CFS recovered after CBT compared with non-POTS-CFS patients (58% vs. 88%, P = 0.017).
Discussion
In this study, the prevalence of POTS in a large CFS cohort of adults and adolescents was 5.7% and 18.2%, respectively, which is much lower than the 27% reported in the review by the IOM. POTS prevalence was not different in patients with CFS who fulfilled the SEID criteria. To the best of our knowledge our cohort of 419 patients with CFS is the largest population studied thus far. Although the prevalence of POTS in the healthy population is unknown, healthy controls in studies reviewed by the IOM reveal a combined prevalence of 4%, which seems to be more in accordance with results from Data were available for all patients, unless stated otherwise, and are shown as number (%) or mean (standard deviation). POTS-CFS, chronic fatigue syndrome with postural orthostatic tachycardia syndrome; non-POTS-CFS, chronic fatigue syndrome without postural orthostatic tachycardia syndrome; CIS, Checklist Individual Strength; SIP, Sickness Impact Profile; BDI, Becks Depression Inventory. *Data missing for three patients. †Data missing for 11 patients.
the present study. This large discrepancy in prevalence could be explained by two methodological issues. First, many of the reported studies were performed in healthcare centres specialized in the assessment of autonomic symptoms, or included patients who were selected based on their symptoms (e.g. dizziness upon standing). This could have led to referral bias and thus an overestimation of the true prevalence [16, 30] . Secondly, in previous studies, the age limit of included patients was not reported [14] [15] [16] , which could mean that adolescents were also included in the CFS sample.
This could have led to a higher prevalence rate in these cohorts than in our sample of adults, although we still found a POTS prevalence of only 18.2% amongst adolescents. As previously reported and found in the present study, orthostatic tachycardia is common in adolescents, and therefore, it has been suggested that different POTS criteria should be used for these patients [31, 32] .
This is the first study to report the POTS prevalence in patients presenting with persistent fatigue but not meeting CFS criteria according to the CDC. The prevalence of POTS in non-CFS patients was not significantly different from that in the CFS population. In particular, in adults, POTS cannot be used to discriminate between CFS and fatigued non-CFS patients. To date, nine different CFS definitions have been proposed, none of which has been proven to discriminate between different causes of fatigue. Other studies even describe 20 different case definitions to be present [33] . Before a new case definition can be introduced and used in daily clinical practice, this has to be validated in order to add value to the existing definitions. Furthermore, the aims of the SEID criteria proposed by the IOM were a better understanding of CFS and a faster diagnosis, but with the described criteria, a large proportion of patients with CFS might not even fulfil the SEID criteria. This could lead to an extension of the diagnostic procedure, and unnecessarily withholding effective treatment.
In line with previous studies, we found that adult patients with POTS-CFS were younger and had a higher heart rate in the supine position, compared to non-POTS-CFS patients [14, 15] . Increased heart rate in the supine position has been reported previously in patients with CFS by our group and could reflect increased sympatho-adrenomedullary activity [34] . These differences between POTS-CFS and non-POTS-CFS patients were not found in adolescents. Fatigue severity and CFS-related symptoms were not different between patients with and without POTS, in agreement with some [16] but not all previously reported studies [14] .
Several pathophysiological mechanisms have previously been described that could be responsible for the development of POTS. Such mechanisms include hypovolaemia [17, 35] , increased sympathetic activity [36] and cardiovascular deconditioning [18] , although it is not clear whether the latter is the cause of POTS or rather a consequence. However, given the fact that patients with CFS are usually less active than healthy control subjects [22] , we assumed deconditioning to be a contributing factor. Although maximum oxygen uptake during exercise is the gold standard to measure deconditioning, actometer scores give an indication of a patient's activity pattern, and both of these methods have not been used previously in patients with POTS-CFS. We did not find differences in the level of physical activity between POTS-CFS and non-POTS-CFS patients, which makes it less likely that deconditioning is the cause of POTS in these patients.
The influence of POTS on CFS treatment outcome has not been investigated previously. For adults, no differences could be found in the response to CBT. However, adolescents with POTS did have a higher fatigue score after treatment, although these patients did not report more POTS-related symptoms. Despite this significant difference, 58% of POTS-CFS adolescents were no longer severely fatigued after treatment, which indicates that treatment is still effective in the majority of patients. We propose the use of a stepped-care approach in adolescents, with evaluation for the presence of POTS in those who do not respond to CBT treatment or those who report vasovagal symptoms. Fortunately, treatment of POTS patients is remarkably successful, which means a combined approach could be effective [37] . Treatment of POTS mainly includes lifestyle interventions, such as preventing dehydration and avoiding extreme heat; in addition, regular exercise should be promoted [13] . There is limited evidence to support pharmacological treatment, for example using aldosterone analogues or beta-adrenergic blockers [35] .
This study has several limitations. First, blood pressure measurement was resumed after a standing period of 5-8 min. This means that the reported values could be slightly underestimating the true prevalence of POTS. Nevertheless, patients with POTS had persistent tachycardia at least until 18 min in the standing position, which is consistent with the findings of others [38] . In previous studies, POTS prevalence was most often based on heart rate after two min in the upright position, without taking into account the remaining eight min of the recommended duration of testing of at least 10 min [10, 13] . In that situation, it should be realized that a transient tachycardia directly after standing is normal [39] . Thus, in daily practice, difficulties are encountered in differentiating those patients with a tachycardia upon standing from those with a normal physiological response, particularly amongst adolescents. Another limitation of the present study is the fact that POTS-related symptoms were not recorded during the active standing test. However, these symptoms were recorded in the diary kept by all participants for 12 days.
Conclusion
In conclusion, in adult patients with CFS, the prevalence of POTS was low and not different from that in the non-CFS fatigued population. In addition, POTS in adult patients with CFS was not related to disease severity, physical activity or treatment outcome. POTS-CFS adolescent patients showed a smaller reduction in fatigue after CBT. However, as most patients still benefit from CBT, there is no reason to withhold such treatment. Based on the results of this study, evaluation for POTS appears to be of limited additional value for the diagnosis of CFS; our findings do not support the addition of POTS to a new CFS case definition as proposed by the IOM. With the new SEID criteria, we are concerned that a subset of patients will not be diagnosed with CFS, although they are not different from other patients with respect to fatigue severity or mental and physical disabilities. This eventually could lead to a delay in starting effective treatment, which is in contrast to the goal of the IOM to accelerate the diagnostic process.
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